Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/20/24
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 12/10/24
End: 05/01/26
Due: 05/01/27
Phase: N/A
Priority: Normal
Start: 03/05/25
End: 08/01/26
Due: 08/01/27
Phase: N/A
Priority: Normal
Start: 04/20/25
End: 02/01/26
Due: 02/01/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| EGM Guided PFA for PerAF | NCT06729866 | Xu Liu | user2@example.com | None | 2024-09-20 | 2025-12-01 | 2026-12-01 | - | - | 2025-07-14 |
| Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation | NCT05883722 | Xu Liu | user2@example.com | None | 2023-06-30 | 2024-12-30 | 2025-12-30 | - | - | 2025-07-14 |
| Efficacy and Safety of Dapagliflozin in Preventing Atrial Fibrillation Recurrence After Catheter Ablation | NCT06740786 | Xu Liu | user2@example.com | None | 2024-12-10 | 2026-05-01 | 2027-05-01 | - | - | 2025-07-14 |
| Impact of Periodontal Therapy on AF Recurrence Post-Ablation in High-Inflammatory Burden Patients | NCT06892808 | Xu Liu | user2@example.com | None | 2025-03-05 | 2026-08-01 | 2027-08-01 | - | - | 2025-07-14 |
| Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy | NCT06947590 | Xu Liu | user2@example.com | None | 2025-04-20 | 2026-02-01 | 2027-02-01 | - | - | 2025-07-14 |